| Similar Articles |
|---|
 |
The Motley Fool
September 1, 2004
Selena Maranjian |
Mutual Fund Fakery Is your expensive, managed fund really an index fund in disguise?   |
The Motley Fool
December 15, 2006
Hope Nelson-Pope |
4 Ways to Retire Well Forget the scary stories -- retirement planning can be easier than you think. |
The Motley Fool
March 3, 2006
Rex Moore |
You Won't Believe What a Half-Percent Will Cost You You shouldn't pay any more than you absolutely have to for a fund that simply tracks an index. Check your index fund's expense ratio today, and then shop around to see if you can do better. |
Popular Mechanics
November 19, 2009
Joe P. Hasler |
Top 6 North American Meteor Showers You Don't Want to Miss A list of upcoming meteor spectacles in the sky. |
The Motley Fool
July 3, 2008
Brian Richards |
The Worst Investment I've Ever Seen Many people do not realize that mutual fund fees are important for making an index fund investment decision. Secondly, even investors who realize fees are important do not minimize index fund fees. |
The Motley Fool
June 20, 2008
Selena Maranjian |
Make Money Despite Higher Fees A low fee isn't everything. |
The Motley Fool
August 27, 2008
Selena Maranjian |
When Buying an Index Fund Is Stupid Not all index funds are created equal. |
The Motley Fool
February 11, 2008
Mary Dalrymple |
Buy the Market -- Cheap! Index funds perform as efficiently as possible by replicating the market's performance for the lowest possible expense. |
The Motley Fool
February 14, 2006
Shruti Basavaraj |
Fools' First Loves: Vanguard Target Retirement Investing in funds doesn't have to stifle your portfolio. Think of it, rather, as a way to maximize your portfolio's returns. |
Financial Planning
February 1, 2007
David Macchia |
Protect Retirement Financial advisors should pay attention to ROI -- not return on investment, but reliability of income. Planners must help clients assess the real capacity of their portfolios to generate long-term retirement income. |
The Motley Fool
August 13, 2008
Chuck Saletta |
Beat the S&P 500 -- Guaranteed! Put a too-often-neglected investing tool, reinvesting index fund dividends, to work for you. |
The Motley Fool
September 19, 2006
Zoe Van Schyndel |
Retirement Planning the Easy Way? As you plan for retirement, a target fund might be worth considering. Make sure that the fund you select matches your risk tolerance and your personal retirement goals. |
The Motley Fool
April 26, 2007
Tom Taulli |
Phase Forward's False Funk Ignore its stagnant shares -- new deals should continue this company's growth. |
The Motley Fool
July 11, 2008
Robert Brokamp |
You Don't Deserve Retirement Here are three reasons why you don't deserve to retire, and how you can change that. |
The Motley Fool
March 25, 2008
Chuck Saletta |
The World's Easiest Retirement Plan Doing anything -- anything at all! -- to prepare for retirement, is better than doing nothing. Read on for our simple plan. |
The Motley Fool
September 9, 2004
Rick Aristotle Munarriz |
Index Fund Fire Sale Index funds are lowering their fees, and you are the winner. |
The Motley Fool
December 10, 2009
Selena Maranjian |
A High IQ Won't Make You a Great Investor We investors, even us smarties, often place more importance on how we think a fund performs than on its fees. |
InternetNews
April 19, 2010 |
Oracle Grabs Health Software Firm Phase Forward In an all-cash deal, Oracle is shelling out $685 million to purchase Phase Forward, a Massachusetts-based firm specializing in software to manage drug data and health science. |
The Motley Fool
March 20, 2009
Tim Hanson |
It's Time to Reinvent the Index Fund The flawed "bigger is better" reasoning that underlies index investing has exposed American investors to needless amounts of risk over the past few years and ultimately cost them billions of dollars of their hard-earned money. |
BusinessWeek
April 19, 2004
Tergesen & Young |
Index Funds Aren't All Equal High costs and managers who hold cash too long -- or pay inflated commissions -- can shave returns. So it pays to compare |
Financial Planning
February 1, 2008
Charles J. Farrell |
Magic Numbers A few simple ratios is all it takes to get -- and keep -- clients focused on long-term goals. |
The Motley Fool
September 20, 2007
Brian Orelli |
Teva's Disappointing Phase 2 Results Teva's lupus drug fails to meet its primary endpoint in its phase 2 trial. Investors, take note. |
The Motley Fool
February 9, 2009
Selena Maranjian |
Do You Sell Too Early? It's interesting to ponder why index funds do so much better than mutual funds that are carefully managed by thinking people who presumably have some stock-evaluation skills. One reason is simply cost. |
The Motley Fool
October 6, 2011
Brian Orelli |
Data Published; Back to Waiting Phase 2 data for Aeterna Zentaris and Keryx's perifosine was published, but it's the phase 3 that's important. |
The Motley Fool
January 9, 2004 |
Alternatives to Index Funds Is it cheaper to choose exchange-traded funds over traditional index funds? |
The Motley Fool
November 3, 2009
Amanda B. Kish |
Why You Won't Be Able to Retire Don't quit your day job just yet! There is a true crisis ahead -- and new data shows just how unprepared most Americans are to retire. |
The Motley Fool
October 1, 2009
Brian Orelli |
Geez, Lighten Up, Mr. Market! Investors dish out undue punishment to Onyx's stock. |
The Motley Fool
July 27, 2007
Tom Taulli |
A New Phase for Phase Forward Phase Forward wins a multi-million dollar contract for its clinical trial software; this infusion of cash provides even more resources for pursuing more growth. |
The Motley Fool
June 7, 2011
Morgan Housel |
Searching for a Better Index Going beyond the S&P 500. For those who don't have the time or inclination to dive into individual stocks, index funds are the way to go. |
The Motley Fool
February 9, 2010
Dan Caplinger |
3 Reasons to Move Beyond Index Funds If you want to take your investing prowess to the next level you'll want to move beyond index funds -- at least with part of your savings. |
The Motley Fool
January 24, 2008
Brian Lawler |
Vertex Under the Gun Vertex announces development plans for its lead drug. Investors, take note. |
The Motley Fool
May 26, 2010
Dan Caplinger |
Your Investing Life Begins at 65 30 years is a long time. Prepare accordingly. |
The Motley Fool
September 27, 2011
Brian Orelli |
Promising Results, But It's Still Early Aeterna Zentaris' investors got a bit of good news yesterday while they wait for phase 3 data for the company's colorectal cancer drug perifosine. |
The Motley Fool
September 17, 2009
Tim Beyers |
Is This the Market's Next Bubble Boy? Has Twitter reached billion-dollar-business status already? |
National Real Estate Investor
August 1, 2005 |
In Progress: The Crossroads Mixed-Use Revitalization Project The $18 million Nationwide Centre in Phase I will include 80,000 sq. ft. of office space for Nationwide Appraisal Services Corp., along with office space for additional tenants. |
The Motley Fool
June 12, 2009
Brian Orelli |
Where Good Drugs Go to Die Human Genome Sciences has the potential to pop if Benlysta's phase 3 trials are a success, but tread lightly, history is not on their side. |
Information Today
September 29, 2015 |
Spiceworks Offers Concierge Service This is a free, personalized resource for helping IT professionals manage their projects of any size and at any phase. |
Financial Planning
January 1, 2012
Charles Farrell |
Retirement by Design Helping investors live off their wealth is a very different business from helping them build wealth. But managing retirement income is something every advisor needs to learn how to do -- and soon. |
The Motley Fool
November 9, 2007
Brian Lawler |
GPC Regroups Pharma GPC Biotech updates investors following a surprising setback on its lead drug. Investors, take note. |
The Motley Fool
November 8, 2010
Brian Orelli |
No Sticking Point Here: Pfizer's Potential Blockbuster Works Translating successful phase 2 results into a positive phase 3 trial can require a bit of luck, especially for a disease such as rheumatoid arthritis where the outcomes are somewhat subjective. |
The Motley Fool
January 12, 2005
Charly Travers |
Alzheimer's Drug on the Horizon? Myriad Genetics' innovative technology creates an investment opportunity. |
The Motley Fool
March 13, 2007
Brian Lawler |
Panacos Springs Ahead Panacos advances its lead drug program. |
The Motley Fool
November 14, 2011
Brian Orelli |
Biotech Uncertainty = Big Upside Potential Aastrom's phase 2 and phase 3 trials don't match up. |
On Wall Street
April 1, 2011
J. Graydon Coghlan |
Retire Later, Collect More If your clients want to receive full Social Security benefits, it's important that they wait until their official retirement age. |
The Motley Fool
September 28, 2006
Brian Lawler |
Myriad Moves Forward The biotech's new cancer candidate passes phase 1 trials. Investors should take note, and make room for Myriad on their radar screens. |
The Motley Fool
April 9, 2007
Selena Maranjian |
The Surprising S&P 500 Learn fun facts about the venerated index, which just turned 50. Many index funds and exchange-traded funds (ETFs) are tied to it. |
AskMen.com
Charles Frisbie |
Guy's Guide To Index Funds Index funds are a good way to diversify your portfolio with modest growth. Learn here how to pick a good one. |
Financial Planning
October 1, 2008
Richard K. Fullmer |
Reducing Retirement Risk How should retirees configure their portfolios for the long term, while not exposing themselves to inappropriate risk? |
The Motley Fool
January 27, 2010
Dan Caplinger |
These Investments Could Steer You Wrong Index funds and exchange-traded funds aren't perfect. |
CRM
April 27, 2012
Leonard Klie |
ROI of Business Analytics Increases Significantly as Solution Matures It grows from 188 percent in initial automation phase to 1,209 percent in the predictive phase, Nucleus Research Finds |
